Skip to content
Triangle logo TriangleGet started
← Full study record

NCT01784068 · BASELINE

Baseline characteristics

Nilotinib Treatment-free Remission Study in CML (Chronic Myeloid Leukemia) Patients · Source last updated 2026-08-13

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms
  1. counts
    1. group Id
      BG000
      value
      215
    units
    Participants
groups
  1. description
    Participants who had received at least 2 years of first-line nilotinib treatment and achieved a deep molecular response (MR4.5) entered the nilotinib treatment consolidation (NTCS) phase. During this phase, participants received nilotinib 300 mg twice daily for 52 weeks.
    id
    BG000
    title
    NTCS Phase
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          lower Limit
          21
          upper Limit
          86
          value
          54.0
    dispersion Type
    FULL_RANGE
    param Type
    MEDIAN
    title
    Age, Continuous
    unit Of Measure
    years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          102
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          113
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          189
      title
      Caucasian
    2. categories
      1. measurements
        1. group Id
          BG000
          value
          20
      title
      Asian
    3. categories
      1. measurements
        1. group Id
          BG000
          value
          3
      title
      Unknown
    4. categories
      1. measurements
        1. group Id
          BG000
          value
          1
      title
      Native American
    5. categories
      1. measurements
        1. group Id
          BG000
          value
          2
      title
      Other
    param Type
    NUMBER
    title
    Race/Ethnicity, Customized
    unit Of Measure
    participants
Complete source fields
denoms
  1. counts
    1. group Id
      BG000
      value
      215
    units
    Participants
groups
  1. description
    Participants who had received at least 2 years of first-line nilotinib treatment and achieved a deep molecular response (MR4.5) entered the nilotinib treatment consolidation (NTCS) phase. During this phase, participants received nilotinib 300 mg twice daily for 52 weeks.
    id
    BG000
    title
    NTCS Phase
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          lower Limit
          21
          upper Limit
          86
          value
          54.0
    dispersion Type
    FULL_RANGE
    param Type
    MEDIAN
    title
    Age, Continuous
    unit Of Measure
    years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          102
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          113
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          189
      title
      Caucasian
    2. categories
      1. measurements
        1. group Id
          BG000
          value
          20
      title
      Asian
    3. categories
      1. measurements
        1. group Id
          BG000
          value
          3
      title
      Unknown
    4. categories
      1. measurements
        1. group Id
          BG000
          value
          1
      title
      Native American
    5. categories
      1. measurements
        1. group Id
          BG000
          value
          2
      title
      Other
    param Type
    NUMBER
    title
    Race/Ethnicity, Customized
    unit Of Measure
    participants

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice